摘要
目的观察替罗非班在急性冠脉综合征合并糖尿病患者介入治疗冠脉内应用的有效性和安全性。方法将84例合并糖尿病急性冠脉综合征患者分为治疗组和对照组,治疗组介入治疗前冠脉内应用替罗非班,并继续静脉泵入替罗非班36h,观察两组患者术中无复流现象发生率、术后左室射血分数、术后30d主要心血管事件(MACE)发生率、不良反应情况。结果两组疗效比较差异显著。结论替罗非班可减少并改善急性冠脉综合征合并糖尿病患者介入术中无复流现象、减少术后血栓形成及心血管事件发生率,并且安全性好。
Objective Observation of tirofiban in patients with acute coronary syndrome coronary intervention effectiveness and safety.Methods 84 amalgamate a diabetes acute coronary artery syndrome patient and is divided into,treated the group and control group,Treat group get involved coronary artery employ until tirofiban class treat,continue vein pump into,take the place of tirofiban 36 hours such as class,Observe two group have,reply,flow phenomenon incidence,postoperative left room ejection fraction of the skill,main energies run affairs piece incidence,bad reaction situation postoperative 30 day.Results Significant difference between two groups.Conclusion Can reduce and improve,amalgamate for tirofiban diabetes acute patient,syndrome of coronary artery,get involved skill have,reply phenomenon of flowing,reduce postoperative thrombosis and energies run affairs a incidence class,and security is good.
出处
《实用心脑肺血管病杂志》
2010年第12期1831-1833,共3页
Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
